Effect of tocilizumab in hospitalized patients with severe pneumonia COVID-19: a cohort study
Benjamin Rossi, View ORCID ProfileLee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, Helene Guillot, Marie-Anne Bouldouyre, View ORCID ProfileYves Allenbach, Joe-Elie Salem, Paul Barsoum, Arezki Oufella, Helene Gros
doi: https://doi.org/10.1101/2020.06.06.20122341
Benjamin Rossi
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Lee S. Nguyen
2Research & innovation of CMC Ambroise Paré, 92200 Neuilly-sur-Seine, France
3Sorbonne Université, INSERM, Clinical Investigations Center Paris-Est, CIC-1901, AP.HP.6 Pitié-Salpétrière, 75013 Paris, France
Philippe Zimmermann
4Department of pharmacy, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Faiza Boucenna
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Louis Dubret
4Department of pharmacy, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Louise Baucher
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Helene Guillot
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Marie-Anne Bouldouyre
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Yves Allenbach
5Sorbonne Université, Department of Internal medicine and Clinical Immunology, AP.HP.6 Pitié-Salpétrière, 75013 Paris, France
Joe-Elie Salem
3Sorbonne Université, INSERM, Clinical Investigations Center Paris-Est, CIC-1901, AP.HP.6 Pitié-Salpétrière, 75013 Paris, France
Paul Barsoum
6Department of cardiology, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Arezki Oufella
4Department of pharmacy, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Helene Gros
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France

Data Availability
data are not available
Posted June 09, 2020.
Effect of tocilizumab in hospitalized patients with severe pneumonia COVID-19: a cohort study
Benjamin Rossi, Lee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, Helene Guillot, Marie-Anne Bouldouyre, Yves Allenbach, Joe-Elie Salem, Paul Barsoum, Arezki Oufella, Helene Gros
medRxiv 2020.06.06.20122341; doi: https://doi.org/10.1101/2020.06.06.20122341
Effect of tocilizumab in hospitalized patients with severe pneumonia COVID-19: a cohort study
Benjamin Rossi, Lee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, Helene Guillot, Marie-Anne Bouldouyre, Yves Allenbach, Joe-Elie Salem, Paul Barsoum, Arezki Oufella, Helene Gros
medRxiv 2020.06.06.20122341; doi: https://doi.org/10.1101/2020.06.06.20122341
Subject Area
Subject Areas
- Addiction Medicine (280)
- Allergy and Immunology (579)
- Anesthesia (140)
- Cardiovascular Medicine (1947)
- Dermatology (184)
- Emergency Medicine (333)
- Epidemiology (11103)
- Gastroenterology (624)
- Genetic and Genomic Medicine (3173)
- Geriatric Medicine (309)
- Health Economics (561)
- Health Informatics (2042)
- Health Policy (863)
- Hematology (310)
- HIV/AIDS (682)
- Medical Education (317)
- Medical Ethics (92)
- Nephrology (334)
- Neurology (2987)
- Nursing (164)
- Nutrition (464)
- Oncology (1552)
- Ophthalmology (478)
- Orthopedics (185)
- Otolaryngology (266)
- Pain Medicine (202)
- Palliative Medicine (57)
- Pathology (403)
- Pediatrics (913)
- Primary Care Research (355)
- Public and Global Health (5592)
- Radiology and Imaging (1095)
- Respiratory Medicine (761)
- Rheumatology (339)
- Sports Medicine (289)
- Surgery (343)
- Toxicology (48)
- Transplantation (159)
- Urology (132)